Stay informed on our events

Upcoming Events

American Diabetes Association 84th Scientific Sessions | June 21st – 24th, 2024

We will be at ADA, taking place in Orlando, FL., June 21–24, 2024. Stop by our Booth (#1154) and learn how our proprietary epigenomic test platform can help you optimize your drug development and how our non-invasive blood test Avantect can help you manage your newly diagnosed type 2 diabetes patients for their increased risk for pancreatic cancer. 

Previous Events

Digestive Disease Week | May 18th – 21st, 2024

We will be at Digestive Disease Week, Washington, DC, May 18th to 21st, 2024. Don't miss our presentation, titled: “Detection of High-Risk Pancreatic Cysts using Avantect™ blood-based test.” 

American Association for Cancer Research | April, 2024

At the American Association for Cancer Research meeting, April 2024 – we presented a poster titled “Plasma cell-free DNA hydroxymethylation profiling reveals anti-PD1 treatment response and resistance biology in non-small cell lung cancer.” 

Precision Med TRI-CON | March, 2024

We attended TRI-CON 2024. If you missed us, contact us to learn about Virtuoso, our epigenomic platform that provides an unprecedented level of clarity to inform cancer diagnosis and treatment. Or, get more information on our presentation! Epigenomic Tools for Early...

European Neuroendocrine Tumor Society | March, 2024

European Neuroendocrine Tumor Society, March 2024 – Oral presentation entitled “ 5-Hydroxymethylcytosine profiling of plasma-derived circulating free DNA in patients with pancreatic neuroendocrine tumors treated with [177Lu]Lu-DOTA-TATE.” 

American Pancreatic Association | December, 2023

American Pancreatic Association, December 2023 – Poster presentation “SAFE-D Trial design: Targeted pancreatic cancer screening to evaluate stage and resectability rate shift in patients with new-onset diabetes.”

American Diabetes Association 83rd Scientific Sessions | June, 2023

American Diabetes Association 83rd Scientific Sessions, June 2023 - Poster presentation entitled “Implementation of the Avantect Pancreatic Cancer Test in Newly Diagnosed Type 2 Diabetes Patients in a Clinical Setting.” Meet Us At ADA Booth #1814 ClearNote Health is a...

Epigenomics-based Tests
for Early Cancer Detection